Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 41% ± 25% | |
GABAergic neuron | 7 studies | 42% ± 22% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 12% | |
interneuron | 5 studies | 42% ± 21% | |
neuron | 4 studies | 19% ± 4% | |
retinal bipolar neuron | 4 studies | 29% ± 8% | |
endothelial cell | 3 studies | 25% ± 7% | |
GABAergic interneuron | 3 studies | 23% ± 4% | |
retinal ganglion cell | 3 studies | 27% ± 10% | |
rod bipolar cell | 3 studies | 76% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 38% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 1039.31 | 2555 / 2642 | 95% | 10.20 | 669 / 705 |
adrenal gland | 100% | 1391.00 | 258 / 258 | 90% | 12.34 | 208 / 230 |
prostate | 97% | 290.20 | 238 / 245 | 91% | 5.07 | 455 / 502 |
intestine | 98% | 278.90 | 945 / 966 | 83% | 5.20 | 438 / 527 |
esophagus | 95% | 270.76 | 1377 / 1445 | 85% | 6.41 | 155 / 183 |
skin | 83% | 188.52 | 1494 / 1809 | 90% | 21.00 | 423 / 472 |
stomach | 91% | 167.38 | 326 / 359 | 79% | 4.80 | 226 / 286 |
thymus | 73% | 100.59 | 475 / 653 | 88% | 6.76 | 532 / 605 |
ovary | 96% | 220.25 | 173 / 180 | 64% | 3.00 | 274 / 430 |
bladder | 90% | 184.67 | 19 / 21 | 65% | 4.63 | 330 / 504 |
lung | 84% | 132.71 | 484 / 578 | 69% | 4.46 | 799 / 1155 |
kidney | 80% | 141.55 | 71 / 89 | 72% | 4.62 | 653 / 901 |
uterus | 91% | 169.85 | 154 / 170 | 59% | 3.27 | 273 / 459 |
breast | 97% | 203.82 | 443 / 459 | 52% | 2.01 | 577 / 1118 |
pancreas | 53% | 68.97 | 175 / 328 | 81% | 4.22 | 145 / 178 |
adipose | 97% | 224.74 | 1166 / 1204 | 0% | 0 | 0 / 0 |
heart | 73% | 144.74 | 627 / 861 | 0% | 0 | 0 / 0 |
muscle | 69% | 107.65 | 554 / 803 | 0% | 0 | 0 / 0 |
liver | 30% | 36.17 | 67 / 226 | 35% | 1.48 | 144 / 406 |
tonsil | 0% | 0 | 0 / 0 | 62% | 4.29 | 28 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 3.39 | 16 / 29 |
spleen | 54% | 73.66 | 129 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 70.60 | 666 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 48% | 2.40 | 38 / 80 |
peripheral blood | 22% | 577.00 | 208 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010706 | Biological process | ganglioside biosynthetic process via lactosylceramide |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0042551 | Biological process | neuron maturation |
GO_0006486 | Biological process | protein glycosylation |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0022010 | Biological process | central nervous system myelination |
GO_0021955 | Biological process | central nervous system neuron axonogenesis |
GO_0070085 | Biological process | glycosylation |
GO_0001572 | Biological process | lactosylceramide biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0008378 | Molecular function | galactosyltransferase activity |
GO_0008489 | Molecular function | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | B4GALT6 |
Protein name | Beta-1,4-galactosyltransferase 6 Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-) |
Synonyms | hCG_25475 |
Description | FUNCTION: Catalyzes the synthesis of lactosylceramide (LacCer) via the transfer of galactose from UDP-galactose to glucosylceramide (GlcCer) . LacCer is the starting point in the biosynthesis of all gangliosides (membrane-bound glycosphingolipids) which play pivotal roles in the CNS including neuronal maturation and axonal and myelin formation (By similarity). . FUNCTION: Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. . FUNCTION: Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. . |
Accessions | ENST00000237019.11 J3QQY9 ENST00000579372.1 ENST00000383131.3 [Q9UBX8-2] ENST00000306851.10 [Q9UBX8-1] G3XA83 Q9UBX8 Q6NT00 |